Literature DB >> 20629044

Enteroviruses and type 1 diabetes: towards a better understanding of the relationship.

Hela Jaïdane1, Pierre Sauter, Famara Sane, Anne Goffard, Jawhar Gharbi, Didier Hober.   

Abstract

Environmental factors, especially viruses, are involved in the initiation or the acceleration of type 1 diabetes (T1D) pathogenesis. Epidemiological data strongly suggest that enteroviruses, such as coxsackievirus B4 (CV-B4), can be associated with T1D. It has been demonstrated that enterovirus infections were significantly more prevalent in at risk individuals, such as siblings of diabetic patients, when they developed anti-beta-cell autoantibodies or T1D, and in recently diagnosed diabetic patients, compared with control subjects. The isolation of CV-B4 from the pancreas of diabetic patients strengthened the hypothesis of a relationship between the virus and the disease. Studies performed in vitro and in vivo in animal models helped to discover mechanisms of the infection of pancreas and other tissues, potentially able to play a role in the pathogenesis of T1D. Interestingly, it cannot be excluded that enteroviruses behave as half-devil half-angel since experimental studies suggest that, in certain conditions, these agents would be able to protect individuals against the disease. All of the plausible mechanisms by which enterovirus may be related to T1D will be reviewed here. (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20629044     DOI: 10.1002/rmv.647

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  30 in total

Review 1.  Control of antiviral immunity by pattern recognition and the microbiome.

Authors:  Iris K Pang; Akiko Iwasaki
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 2.  Blood-based signatures in type 1 diabetes.

Authors:  Susanne M Cabrera; Yi-Guang Chen; William A Hagopian; Martin J Hessner
Journal:  Diabetologia       Date:  2015-12-23       Impact factor: 10.122

Review 3.  Genome-virome interactions: examining the role of common viral infections in complex disease.

Authors:  Ellen F Foxman; Akiko Iwasaki
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

Review 4.  Enterovirus and type 1 diabetes: What is the matter?

Authors:  Carla Sanchez Bergamin; Sergio Atala Dib
Journal:  World J Diabetes       Date:  2015-06-25

5.  Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells.

Authors:  Ilka Engelmann; Enagnon K Alidjinou; Antoine Bertin; Johann Bossu; Céline Villenet; Martin Figeac; Famara Sane; Didier Hober
Journal:  Cell Mol Life Sci       Date:  2017-06-10       Impact factor: 9.261

Review 6.  The pathogenesis and natural history of type 1 diabetes.

Authors:  Mark A Atkinson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

7.  Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor.

Authors:  Hela Jaïdane; Delphine Caloone; Pierre-Emmanuel Lobert; Famara Sane; Olivier Dardenne; Philippe Naquet; Jawhar Gharbi; Mahjoub Aouni; Vincent Geenen; Didier Hober
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

Review 8.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes.

Authors:  D Hober; F Sane; H Jaïdane; K Riedweg; A Goffard; R Desailloud
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 9.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: enterovirus, thymus and type 1 diabetes pathogenesis.

Authors:  H Jaïdane; F Sané; R Hiar; A Goffard; J Gharbi; V Geenen; D Hober
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

10.  Evaluation of Contamination Risks with Coxsackievirus B4 E2 in Swiss Albino Mice Stools.

Authors:  Leïla Aguech-Oueslati; Hela Jaidane; Famara Sane; Nedia Jrad-Battikh; Sabrine Ben Hamed; Didier Hober; Jawhar Gharbi
Journal:  Curr Microbiol       Date:  2017-08-30       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.